Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 200 #1
TickerFPP [AMEX]
CompanyFieldpoint Petroleum Corp.
CountryUSA
IndustryIndependent Oil & Gas
Market Cap15.98MEPS (ttm)-0.25
P/E-EPS this Y-260.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-26.62%
P/S1.74EPS next 5Y-
P/B1.45EPS Q/Q-
Dividend-Sales Q/Q-50.00%
Insider Own33.80%Inst Own10.90%
Insider Trans-8.71%Inst Trans2.71%
Short Float0.37%EarningsFeb 13/b
Analyst Recom-Target Price-
Avg Volume30.48K52W Range0.91 - 5.86
Apr-20-15 02:31AMCompletion of £3.4 million Subscription at noodls
Apr-03-15 01:04PMFIELDPOINT PETROLEUM CORP Financials
Mar-31-15 09:09PMManagement Updates at noodls
Mar-31-15 05:10PMFIELDPOINT PETROLEUM CORP Files SEC form 8-K, Regulation FD Disclosure
Mar-30-15 04:30PMFieldPoint Petroleum Reports Results For Fiscal Year 2014 PR Newswire
Mar-30-15 04:27PMFIELDPOINT PETROLEUM CORP Files SEC form 10-K, Annual Report
Mar-12-15 04:02AMH2 2014 Operational Update at noodls
Mar-10-15 02:10PMFieldPoint Petroleum suspends all drilling projects at bizjournals.com
Mar-10-15 08:00AMFieldPoint Petroleum Provides Update PR Newswire
Feb-12-15 03:57AMRNS Akmola gold update at noodls
TickerCANF [AMEX]
CompanyCan-Fite BioPharma Ltd.
CountryIsrael
IndustryBiotechnology
Market Cap35.07MEPS (ttm)-0.68
P/E-EPS this Y70.00%
Forward P/E-EPS next Y9.50%
PEG-EPS past 5Y0.00%
P/S-EPS next 5Y-
P/B5.48EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float5.05%Earnings-
Analyst Recom2.70Target Price2.70
Avg Volume268.71K52W Range1.85 - 5.83
Apr-27-15 07:03AM7:03 am Can-Fite BioPharma reports positive results from further analysis of Phase II/III Psoriasis trial; Data suggest CF101 as potential first-line systemic therapy for patients with moderate-severe psoriasis
Apr-27-15 07:00AMCan-Fite Reports Positive Results from Further Analysis of Phase II/III Psoriasis Trial PR Newswire
Apr-20-15 07:00AMCan-Fite Applies for Orphan Drug Designation in Europe for CF102 in the Treatment of Liver Cancer PR Newswire
Apr-15-15 06:48PMCANF: Initiating Research Coverage On Can-Fite Biopharma
Apr-02-15 01:04PMCAN-FITE BIOPHARMA LTD. Financials
Mar-30-15 10:00PMCAN-FITE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Can-Fite BioPharma Ltd. Following Announcement of Psiorasis Drug Trial Results Business Wire
Mar-30-15 03:07PMCan-Fite BioPharma (CANF) Stock Plummets to 52-Week Low Today on Psiorasis Drug Trial Results at TheStreet
Mar-30-15 12:05PMCan-Fite BioPharma downgraded by ROTH Capital
Mar-30-15 09:11AMCan-Fite Reports Top-Line Results from Phase II/III Trial for CF101 in Treatment of Psoriasis PR Newswire
Mar-27-15 04:29PMCan-Fite Files 2014 Annual Report on Form 20-F PR Newswire
TickerVLTC [NASD]
CompanyVoltari Corporation
CountryUSA
IndustryDiversified Communication Services
Market Cap83.62MEPS (ttm)-7.18
P/E-EPS this Y-11.20%
Forward P/E-EPS next Y-
PEG-EPS past 5Y34.90%
P/S6.85EPS next 5Y25.00%
P/B-EPS Q/Q-106.00%
Dividend-Sales Q/Q21.90%
Insider Own0.20%Inst Own56.10%
Insider Trans0.00%Inst Trans397.49%
Short Float18.55%Earnings-
Analyst Recom3.00Target Price1.79
Avg Volume2.88M52W Range0.63 - 21.75
Apr-27-15 06:06PMNasdaq stocks posting largest percentage decreases
Apr-25-15 12:07AMCharting the Market at Barrons.com
Apr-24-15 02:43PMVoltari (VLTC) Stock Continues to Gain Today Following Icahn's Increased Stake at TheStreet
Apr-23-15 03:17PMThe education of a trader: trading on tilt (video)
Apr-23-15 10:42AMVoltari (VLTC) Stock Is Down Today, Shedding Some Gains at TheStreet
Apr-22-15 10:23AMVoltari (VLTC) Stock Just Won't Quit, Continues to Soar Today at TheStreet
Apr-22-15 12:00AMIcahn Investment Turns Penny Stock Voltari Into Bottle Rocket at Bloomberg
Apr-22-15 12:00AMA Carl Icahn Investment Has Surged 12-Fold In The Last Month
Apr-21-15 10:50AMVoltari (VLTC) Stock Keeps Surging Today Following Icahn's Increased Stake at TheStreet
TickerLOOK [NASD]
CompanyLookSmart, Ltd.
CountryUSA
IndustryInternet Information Providers
Market Cap9.21MEPS (ttm)-1.12
P/E-EPS this Y-20.40%
Forward P/E-EPS next Y-
PEG-EPS past 5Y0.90%
P/S1.96EPS next 5Y-
P/B3.79EPS Q/Q29.40%
Dividend-Sales Q/Q-40.00%
Insider Own57.51%Inst Own16.90%
Insider Trans0.00%Inst Trans-0.20%
Short Float2.22%EarningsFeb 13/a
Analyst Recom-Target Price-
Avg Volume273.35K52W Range0.39 - 2.88
Apr-24-15 03:30PMLookSmart To Spin Off Ops, Get Acquired By Greek Shipper Benzinga
Apr-24-15 02:44PMLookSmart (LOOK) Stock Skyrocketing Today on Spin Off, Merger Announcement at TheStreet
Apr-23-15 05:22PMLOOKSMART LTD Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Sta
Apr-23-15 05:02PMLookSmart Announces Spin-Off and Definitive Merger Agreement with Pyxis at noodls
Apr-23-15 04:39PMLookSmart Announces Spin-Off and Definitive Merger Agreement with Pyxis PR Newswire
Mar-31-15 07:55AMLOOKSMART LTD Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra
Mar-24-15 01:04PMLOOKSMART LTD Financials
Mar-17-15 05:29PMLOOKSMART LTD Files SEC form 10-K, Annual Report
Feb-02-15 06:03AMLOOKSMART LTD Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra
Jan-06-15 04:09PMAOL Surges, General Electric Drops: Tech Winners & Losers at TheStreet
TickerCNYD [NASD]
CompanyChina Yida Holding, Co.
CountryChina
IndustryPersonal Services
Market Cap9.75MEPS (ttm)-5.66
P/E-EPS this Y-32.60%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-22.60%
P/S0.74EPS next 5Y-
P/B0.09EPS Q/Q35.10%
Dividend-Sales Q/Q-6.80%
Insider Own57.77%Inst Own23.60%
Insider Trans0.00%Inst Trans-8.72%
Short Float0.23%Earnings-
Analyst Recom1.00Target Price11.50
Avg Volume1.43K52W Range1.82 - 5.50
Apr-07-15 01:04PMCHINA YIDA HOLDING, CO. Financials
Mar-31-15 03:29PMCHINA YIDA HOLDING, CO. Files SEC form 10-K, Annual Report
Mar-05-15 12:57PMCHINA YIDA HOLDING, CO. Files SEC form 10-Q/A, Quarterly Report
Mar-05-15 12:46PMCHINA YIDA HOLDING, CO. Files SEC form 10-K/A, Annual Report
Jan-30-15 05:53AMChina Minsheng Investment eyes Southeast Asia with $1.5 billion Reuters
Dec-04-14 02:02PMCHINA YIDA HOLDING, CO. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-14-14 04:08PMCHINA YIDA HOLDING, CO. Files SEC form 10-Q, Quarterly Report
Oct-20-14 04:33PM3 Diversified Services Stocks Nudging The Industry Higher at TheStreet
Sep-02-14 05:26PMCHINA YIDA HOLDING, CO. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Def
TickerWPCS [NASD]
CompanyWPCS International Incorporated
CountryUSA
IndustryDiversified Communication Services
Market Cap3.26MEPS (ttm)-15.43
P/E-EPS this Y63.40%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-26.30%
P/S0.12EPS next 5Y-
P/B-EPS Q/Q48.50%
Dividend-Sales Q/Q1.60%
Insider Own1.81%Inst Own6.40%
Insider Trans0.00%Inst Trans49.08%
Short Float-EarningsMar 24/b
Analyst Recom-Target Price12.00
Avg Volume45.15K52W Range3.40 - 38.06
Apr-20-15 04:30PMWPCS Stockholders Overwhelmingly Approve Authorization for Reverse Stock Split Proposal Marketwired
Apr-17-15 04:32PMWPCS INTERNATIONAL INC Files SEC form 8-K, Unregistered Sale of Equity Securities
Apr-16-15 04:31PMWPCS INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submissio
Apr-10-15 04:32PMWPCS INTERNATIONAL INC Files SEC form 8-K, Unregistered Sale of Equity Securities
Apr-08-15 04:30PMSuisun City Operations Signs $14.4 Million in New Contracts in March Marketwired
Apr-03-15 11:14AMWPCS INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-27-15 01:04PMWPCS INTERNATIONAL INC Financials
Mar-26-15 04:31PMWPCS INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-23-15 05:52PMWPCS Announces Financial Results for Fiscal 2015 Third Quarter and Nine-Month Periods Marketwired
Mar-23-15 04:30PMWPCS INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report
TickerSYMX [NASD]
CompanySynthesis Energy Systems, Inc.
CountryUSA
IndustrySpecialty Chemicals
Market Cap156.92MEPS (ttm)-0.54
P/E-EPS this Y33.30%
Forward P/E-EPS next Y-
PEG-EPS past 5Y18.20%
P/S7.97EPS next 5Y-
P/B2.52EPS Q/Q-
Dividend-Sales Q/Q-33.90%
Insider Own3.90%Inst Own11.90%
Insider Trans0.82%Inst Trans-9.68%
Short Float0.93%EarningsMay 07
Analyst Recom-Target Price3.00
Avg Volume166.04K52W Range0.63 - 1.95
Apr-27-15 01:59PMSynthesis Energy Systems (SYMX) Stock Spikes Today on Increased Paulson Hedge Fund Stake at TheStreet
Apr-27-15 11:32AMSYNTHESIS ENERGY SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Apr-25-15 06:45PMJohn Paulson Buys 12% Stake in Synthesis Energy Systems
Apr-20-15 05:01PMSYNTHESIS ENERGY SYSTEMS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Apr-20-15 09:15AMSynthesis Energy Systems Announces Closing of $12 Million Registered Direct Offering at noodls
Apr-20-15 09:00AMSynthesis Energy Systems Announces Closing of $12 Million Registered Direct Offering GlobeNewswire
Apr-17-15 05:01PMSYNTHESIS ENERGY SYSTEMS INC Files SEC form 8-K, Other Events
Apr-15-15 09:30AMSynthesis Energy Systems, Inc. Regains NASDAQ Compliance at noodls
Apr-15-15 09:00AMSynthesis Energy Systems, Inc. Regains NASDAQ Compliance GlobeNewswire
Apr-14-15 03:33PMSYNTHESIS ENERGY SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
TickerATRA [NASD]
CompanyAtara Biotherapeutics, Inc.
CountryUSA
IndustryBiotechnology
Market Cap1.18BEPS (ttm)-3.00
P/E-EPS this Y66.00%
Forward P/E-EPS next Y-38.70%
PEG-EPS past 5Y0.00%
P/S-EPS next 5Y-
P/B2.33EPS Q/Q-368.90%
Dividend-Sales Q/Q-
Insider Own1.40%Inst Own64.60%
Insider Trans2.96%Inst Trans16.90%
Short Float3.33%Earnings-
Analyst Recom1.70Target Price34.00
Avg Volume168.57K52W Range9.66 - 64.35
Apr-27-15 06:06PMNasdaq stocks posting largest percentage decreases
Apr-20-15 06:46AMEBV-CTL Clinical Trial Data Presented by Atara Biotherapeutics' Collaborating Investigators at a Plenary Session at the American Association for Cancer Research Annual Meeting 2015 at noodls
Apr-20-15 06:30AMEBV-CTL Clinical Trial Data Presented by Atara Biotherapeutics' Collaborating Investigators at a Plenary Session at the American Association for Cancer Research Annual Meeting 2015 GlobeNewswire
Apr-19-15 08:55AMAtara Biotherapeutics' Collaborating Investigators' Abstract on T-Cell Therapy for EBV Lymphoma to be Presented at a Clinical Trials Plenary Session at the American Association for Cancer Research Annual Meeting 2015 is Now Available at noodls
Apr-19-15 08:30AMAtara Biotherapeutics' Collaborating Investigators' Abstract on T-Cell Therapy for EBV Lymphoma to be Presented at a Clinical Trials Plenary Session at the American Association for Cancer Research Annual Meeting 2015 is Now Available GlobeNewswire
Apr-16-15 03:56PMThe Top 5 Best IPO Performers in the Last Year at TheStreet
Apr-15-15 06:36PMSeth Klarman Nearly Doubles Stake in Atara Biotherapeutics
Apr-13-15 06:37AMAtara Biotherapeutics, Inc. to Present at the 2015 Jefferies Immuno-Oncology Summit at noodls
Apr-13-15 06:30AMAtara Biotherapeutics, Inc. to Present at the 2015 Jefferies Immuno-Oncology Summit GlobeNewswire
TickerUAMY [AMEX]
CompanyUnited States Antimony Corp.
CountryUSA
IndustryIndustrial Metals & Minerals
Market Cap93.79MEPS (ttm)-0.03
P/E-EPS this Y0.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-24.60%
P/S8.68EPS next 5Y-
P/B7.10EPS Q/Q100.00%
Dividend-Sales Q/Q4.00%
Insider Own23.08%Inst Own16.10%
Insider Trans0.00%Inst Trans1.96%
Short Float1.00%Earnings-
Analyst Recom2.00Target Price3.00
Avg Volume33.90K52W Range0.47 - 2.02
Apr-27-15 08:02AM8:02 am U.S. Antimony reports Los Juarez drill results
Apr-27-15 08:00AMU.S. Antimony Reports Los Juarez Drill Results Business Wire
Mar-21-15 01:04PMUNITED STATES ANTIMONY CORP Financials
Mar-12-15 02:00PMUNITED STATES ANTIMONY CORP Files SEC form 8-K/A, Other Events
Mar-12-15 10:51AMCORRECTING and REPLACING U.S. Antimony Reports All-Time Record Production Business Wire
Mar-12-15 10:51AMCORRECTING and REPLACING U.S. Antimony Reports All-Time Record Production Business Wire
Mar-12-15 08:02AMUNITED STATES ANTIMONY CORP Files SEC form 8-K, Other Events
Mar-09-15 05:17PMU.S. Antimony Announces Investor Conference Call Business Wire
Dec-18-14 06:02AMUNITED STATES ANTIMONY CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Results of Opera
Nov-20-14 12:29PMUNITED STATES ANTIMONY CORP Files SEC form 8-K, Regulation FD Disclosure
TickerCRBP [NASD]
CompanyCorbus Pharmaceuticals Holdings, Inc.
CountryUSA
IndustryBiotechnology
Market Cap78.52MEPS (ttm)-0.10
P/E-EPS this Y-400.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y0.00%
P/S-EPS next 5Y-
P/B13.13EPS Q/Q-400.00%
Dividend-Sales Q/Q-
Insider Own10.20%Inst Own-
Insider Trans-Inst Trans-
Short Float0.00%Earnings-
Analyst Recom2.00Target Price-
Avg Volume27.52K52W Range2.00 - 4.95
Apr-22-15 07:45AMCORBUS PHARMACEUTICALS HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a D
Apr-22-15 07:05AMCorbus Pharmaceuticals Receives $5 Million Development Award From Cystic Fibrosis Foundation Therapeutics to Advance Resunab(TM) Clinical Program Marketwired
Apr-21-15 01:04PMCORBUS PHARMACEUTICALS HOLDINGS, INC. Financials
Apr-16-15 10:22AMCorbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) to Ring The Nasdaq Stock Market Closing Bell at noodls
Apr-16-15 10:00AMCorbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
Apr-16-15 07:51AMCORBUS PHARMACEUTICALS HOLDINGS, INC. Files SEC form 8-K, Other Events
Apr-16-15 07:35AMCorbus Pharmaceuticals Announces Initiation of Trading on The Nasdaq Capital Market Marketwired
Apr-13-15 03:07PMCorbus Pharmaceuticals Announces Uplisting to The NASDAQ Capital Market Marketwired
Apr-02-15 04:44PMCORBUS PHARMACEUTICALS HOLDINGS, INC. Files SEC form 8-K, Other Events
Apr-01-15 08:00AMCorbus Pharmaceuticals Announces Presentation of Positive Data on Anti-Fibrotic Effects of Resunab(TM) in a Preclinical Model of Lung Fibrosis at the Experimental Biology 2015 Scientific Conference Marketwired
1 2 3 4 5 6 ... 10 ... 20 next